Institute For Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, Gangwon-do 24252, Republic of Korea.
Hana Oriental Clinic, Chucnheon, Gangwon-do 24433, Republic of Korea.
Chin J Nat Med. 2017 Aug;15(8):561-575. doi: 10.1016/S1875-5364(17)30084-5.
Korean oriental medicine prescription is widely used for the treatment of gouty diseases. In the present study, we investigated anti-inflammatory effects of modified Korean herbal formulation, mixed extract of medicinal herbs (MEMH), and its modulatory effects on inflammatory mediators associated with gouty arthritis. Both in vitro and in vivo studies were carried out to assess the anti-inflammatory efficacy of MEMH on monosodium urate (MSU) crystals-induced gouty inflammation. MSU crystals stimulated human chondrosarcoma cell line, SW1353, and human primary chondrocytes were treated with MEMH in vitro. The expression levels of pro-inflammatory mediators and metalloproteases were analyzed. The effect of MEMH on NFκB signaling pathway in SW1353 cells was examined. Effect of MEMH on the mRNA expression level of pro-inflammatory mediators and chemotactic factor from human monocytic cell line, THP-1, was also analyzed. The probable role of MEMH in the differentiation process of osteoblast like cells, SaOS-2, after MSU treatment was also observed. To investigate the effects of MEMH in vivo, MSU crystals-induced ankle arthritic model was established. Histopathological changes in affected joints and plasma levels of pro-inflammatory mediators (IL-1β and TNFα) were recorded. MEMH inhibited NFκB signaling pathway and COX-2 protein expression in chondrocytes. MSU-induced mRNA expressions of pro-inflammatory mediators and chemotactic cytokines were suppressed by MEMH. In MSU crystals-induced ankle arthritic mouse model, administration of MEMH relieved inflammatory symptoms and decreased the plasma levels of IL-1β and TNFα. The results indicated that MEMH can effectively inhibit the expression of inflammatory mediators in gouty arthritis, demonstrating its potential for treating gouty arthritis.
韩国东方医学处方广泛用于治疗痛风病。在本研究中,我们研究了改良韩国草药配方(MEMH)的抗炎作用及其对与痛风性关节炎相关的炎症介质的调节作用。进行了体内和体外研究,以评估 MEMH 对尿酸单钠(MSU)晶体诱导的痛风性炎症的抗炎功效。MSU 晶体刺激人软骨肉瘤细胞系 SW1353,并用 MEMH 处理人原代软骨细胞。分析了促炎介质和金属蛋白酶的表达水平。检查了 MEMH 对 SW1353 细胞中 NFκB 信号通路的影响。还分析了 MEMH 对人单核细胞系 THP-1 中促炎介质和趋化因子的 mRNA 表达水平的影响。还观察了 MEMH 在 MSU 处理后成骨样细胞 SaOS-2 分化过程中的可能作用。为了研究 MEMH 的体内作用,建立了 MSU 晶体诱导的踝关节关节炎模型。记录受影响关节的组织病理学变化和促炎介质(IL-1β和 TNFα)的血浆水平。MEMH 抑制了软骨细胞中的 NFκB 信号通路和 COX-2 蛋白表达。MEMH 抑制了 MSU 诱导的促炎介质和趋化细胞因子的 mRNA 表达。在 MSU 晶体诱导的踝关节关节炎小鼠模型中,MEMH 的给药缓解了炎症症状并降低了血浆中 IL-1β和 TNFα的水平。结果表明,MEMH 可有效抑制痛风性关节炎中炎症介质的表达,表明其治疗痛风性关节炎的潜力。